Other Information
+Added: On August 15, 2022, in connection with the consummation of the Private
+Added: Placement, the Company entered into an amended and restated registration statement with Acuitas, which amended and restated that certain
+Added: Registration Rights Agreement, dated as of June 10, 2021, by and between the Company and Acuitas (the “Existing Registration Rights
+Added: Agreement”), to amend the definition of “Registrable Securities” in the Existing Registration Rights Agreement to include
+Added: the PIPE Shares and the Warrant Shares as Registrable Securities thereunder.
+Added: Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K/A (File No.
+Added: 001-39015) filed on July 18, 2022).
+Added: Securities Purchase Agreement, dated July 15, 2022, by and between the Company and Acuitas Group Holdings, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K/A (File No.
+Added: 001-39015) filed on July 18, 2022).
+Added: Amended and Restated Registration Rights Agreement, dated August 15, 2022, by and between BioVie Inc.
+Added: and Acuitas Group Holdings, LLC.
+Added: Controlled Equity Offering SM Sales Agreement, dated August 31, 2022, by and among BioVie Inc.
+Added: Cantor Fitzgerald & Co.
+Added: Riley Securities, Inc.
+Added: (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (File No.
+Added: 001-39015) filed on August 31, 2022).
Certification of Chief Executive Officer (Principal Executive Officer) required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended.
20 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.